Key points are not available for this paper at this time.
We report an efficient metal-free and scalable reductive etherification method to synthesize hindered ethers using chlorodimethylsilane (CDMS) and catalytic Schreiner thiourea. The reaction relies on in situ generated HCl and thiourea via anion-binding catalysis, activating carbonyls to form an oxocarbenium intermediate and enabling hydride transfer to create an ether bond. A broad substrate scope (89 substrates) and excellent functional group tolerance including complex ethers of steroids, terpenoids, peptides, and late-stage ritonavir modification have been demonstrated for this method.
Pareek et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: